We use cookies necessary to giving you a better online experience. By using our website you consent to all cookies in accordance with our Privacy Policy.
Yes, I accept
Menu
Search Opener
Stockholm, Sweden

ESTRO 2026

Session

Sunday
May 17
15:15 - 16:15
K11
Head & neck cancer 2
Ahmed Gawish, Germany;
Enis Ozyar, Turkey
Poster Discussions
Clinical
15:15 - 16:15
A systematic analysis of the exact recurrence location after radiotherapy for laryngeal, hypopharyngeal and oropharyngeal cancer
cornelis raaijmakers, The Netherlands
-3948
15:15 - 16:15
Implementing Personalised Follow-Up for Head and Neck Cancer Survivors: A Two-Year Mixed-Methods Evaluation in Routine NHS Practice
Laura Dean, United Kingdom
-2757
15:15 - 16:15
Immune Checkpoint Inhibitors in Locally Advanced Head and Neck Cancer: A Systematic Review and Network Meta-Analysis
Carlotta Becherini, Italy
-4806
15:15 - 16:15
Predictive modeling of outcomes in salivary gland cancers using machine learning: simulated prospective validation with the RTOG 1008 trial
Federico Lorenzo, Uruguay
-1132
15:15 - 16:15
Isolated nodal failures after de-intensified elective radiotherapy in head and neck cancer: systematic review and meta-analysis
Philipp Schröter, Germany
-2613
15:15 - 16:15
Survival outcomes of radiotherapy alone versus concurrent chemoradiotherapy in T1-2 head and neck cancer with low-volume disease: a multicenter study
Chuanhao Zhang, China
-680
15:15 - 16:15
Comparison of Hypnosis, Music Therapy and Anxiolytic Premedication for Anxiety Management During Head and Neck Radiotherapy: The HYMACO Study
Sophie RENARD, France
-2110
15:15 - 16:15
Improved outcome prediction in nasopharyngeal carcinoma using pre-treatment MRI radiomics
Guanzhi Zhou, The Netherlands
-1253
15:15 - 16:15
FMISO PET/CT-guided dose escalation in advanced head and neck cancer: dosimetric feasibility and acute toxicity of prospective multicenter study
Tomas Blazek, Czech Republic
-3369